Researchers who have experienced a mid-protocol supply disruption, where they could not obtain their peptide for two or three weeks mid-study, understand this viscerally
The company provides the technology infrastructure, the patient portal, and the customer coordination that make the telehealth experience possible
Current Market Pricing (Without Insurance) For context, currently available medications in Canada cost approximately: Wegovy (Semaglutide): $450-550 CAD per month Mounjaro/Zepbound (Tirzepatide): $400-500 CAD per month Saxenda (Liraglutide): $500-600 CAD per month Expected Retatrutide Pricing Eli Lilly typically prices competitively
Discrepancies during the screening process were resolved by consulting the clinical experts and methodologists
The challenge is to support innovation while maintaining clinical standards and patient protection
Figures above are market estimates for research and educational purposes only not a quote, an offer, or medical advice